The current study aims to obtain proof-of-principle that the inhibition of IRAP activity with either of the two structurally distinct, small molecular weight and specific inhibitors of the enzyme, HFI149 and SJM164, protects against focal ischemic damage in a conscious model of stroke using the spontaneously hypertensive rat (SHR). The gene discussed is LNPEP; the disease is stroke disorder.